Millipore Shares Soar on Rumors of a $6B Buyout Bid from Thermo Fisher | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Millipore climbed as high as $102.91 — a 44 percent rise from its Friday closing price of $71.34 — after a report from Bloomberg claimed that Thermo Fisher Scientific has made an unsolicited $6 billion bid to acquire the firm.

A Thermo Fisher spokesperson said the firm would not comment on the "rumor," and Millipore did not respond to a request for comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.